Description | The antibody 47D1 is a human mAb specific for SARS-CoV-2 Spike S1 protein. The antibody binds only to one side of the receptor binding surface on the RBD. Neutralization by the antibody is achieved independent of interfering RBD-ACE2 binding. A crystal structure of the mAb-RBD complex shows that the IF motif at the tip of the antibody CDR H2 interacts with a hydrophobic pocket in the RBD. It neutralizes SARS-CoV-2 by suppressing spike-mediated membrane fusion, rather than blocking virus binding to ACE2-expressing cells. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | SARS-CoV-2 |
Epitope | Receptor-binding domain (RBD) |
Function | Suppresses spike-mediated membrane fusion, but not blocking the virus binding to ACE2-expressing cells. |
Isotype | IgG1 |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA, Neut |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Western Blot Protocol |
Target | SARS-CoV-2 |
Alternative Name | Severe acute respiratory syndrome coronavirus 2 |
Research Area | Coronavirus Disease 2019 |
Related Disease | Coronavirus Disease 2019 |